000538 云南白药
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额3,261,6173,502,7423,209,4105,223,2783,828,907
投资活动产生之现金流量净额(205,583)518,581(6,316,083)3,998,6961,086,494
筹资活动产生之现金流量净额(3,145,515)(2,918,042)(2,733,304)(4,622,683)(2,978,443)
汇率变动对现金及现金等价物的影响(49)2,32516,272(7,154)(3,437)
现金及现金等价物净增加/(减少)(89,529)1,105,605(5,823,705)4,592,1381,933,519
期初现金及现金等价物余额14,151,76513,046,16018,869,86514,277,72712,344,207
期末现金及现金等价物余额14,062,23714,151,76513,046,16018,869,86514,277,727